About this trial
The goal of this observational study is to assess the efficacy that the addition of novel markers cardiac function, particularly of right ventricular (RV) function in echocardiography, and ECG have in detecting pulmonary hypertension.
The main questions it aims to answer are:
Can novel markers in ECG and echocardiography suggest the presence of PH? Can existing screening guidelines be improved with the addition of these markers?
Eligibility criteria
Qualifiers
Patients 18+ who have undergone TTE, ECG and RHC as part of their clinical care
Disqualifiers
Patients <18 years old
Known or suspected congenital heart disease
Patient has opted-out of allowing their data to be used for research and planning (via the national data opt-out choice in England, or equivalent data protection scheme in Scotland)
Trial design
Treatments tested in this trial
- Electrocardiogram
- Transthoracic echocardiogram
- Right heart catheter
Treatment groups
Sponsors and collaborators
Royal United Hospitals Bath NHS Foundation Trust
Lead sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Collaborator
Royal Free Hospital NHS Foundation Trust
Collaborator
Golden Jubilee National Hospital
Collaborator
Papworth Hospital NHS Foundation Trust
Collaborator
University of Bath
Collaborator